While the immunomodulatory roles of PAK1 and PAK4 in PDA have been investigated, the impact of PAK on tumour vasculature and how these vascular changes influence the immune system, including T-cells and dendritic cells, remains poorly understood. The gene discussed is PAK1; the disease is Patent ductus arteriosus.